Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Comparison of Sequential Therapies With Sunitinib and Sorafenib in Advanced Renal Cell Carcinoma

NCT01481870 is registered in ClinicalTrials.gov with Yamagata University as lead sponsor.

NCT NCT01481870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01481870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Comparison of Sequential Therapies With Sunitinib and Sorafenib in Advanced Renal Cell Carcinoma
Lead sponsor
Yamagata University
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2010
Completion date
December 31, 2015
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic renal cell carcinoma